Nevertheless, little is known about the exact effect of enhanced CD38 expression and extracellular ADO production or their mediated immune-suppressive impact linked to the PD-1/PD-L1 axis in mature B-cell lymphomas. Here, CD38 is linked to B-cell non-Hodgkin lymphoma.